The Uterine Manipulation Devices Market was valued at USD 297.7 Million in 2022, and now it is expected to grow with a CAGR of 6.1% from 2023 to 2033. Increased acceptance of minimally invasive or non-invasive procedures, as well as technical improvements, are among the primary drivers propelling the industry in recent years. The market accounted for an absolute dollar opportunity of nearly USD 255.2 Million from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Uterine Manipulation Devices Market (2023) | USD 315 Million |
| Global Uterine Manipulation Devices Market (2033) | USD 570.3 Million |
| Global Uterine Manipulation Devices Market CAGR (2023 to 2033) | 6.1% |
| USA Uterine Manipulation Devices Market CAGR (2023 to 2033) | 6.2% |
| Key Companies Profiled | Conkin Surgical Instruments Ltd.; Johnson and Johnson; CooperSurgical, Inc.; B. Braun Medical Ltd.; KARL STORZ GmbH & Co. KG; CONMED Corporation; RUDOLF Medical GmbH + Co. KG; LiNA Medical ApS; Richard Wolf GmbH; Utah Medical Products, Inc.; Purple Surgical; Clinical Innovations, LLC; Bissinger Medizintechnik |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Uterine Manipulation Devices Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Uterine Manipulation Devices increased at around 5.4% CAGR. The market is projected to grow at a CAGR of 6.1% over the coming ten years.
The rising frequency of various gynecological problems, as well as the rising use of uterine manipulation devices due to their ease of use and comfort, are likely to fuel market expansion throughout the forecast period. UF tumors become more common as women become older, with over 30% of women between the ages of 40 and 60 suffering from them.
Women in their late 40s and early 50s are most likely to acquire UF tumors, while they can develop at any age. Because of the growing number of women with UF tumors, the number of hysterectomy procedures has increased, resulting in a substantial need for uterine manipulation devices.
Principal Consultant
Due to the lower risk involved with these procedures, minimally invasive and non-invasive surgeries are becoming increasingly popular. Smaller incisions reduce postoperative pain and speed healing owing to which these treatments are so widely used. Laparoscopic or robotic-assisted hysterectomy, for example, is a less intrusive procedure for removing the uterus.
A small incision in the lower belly is created, and a miniature camera and small, specialized equipment are inserted and utilized to remove the object. Minimally invasive techniques, on the other hand, have a lower risk of blood loss and infection than open surgery. As a result, a rise in patient demand for non-invasive or minimally invasive therapy, as well as the benefits provided by these procedures, is likely to propel the market at a rapid pace over the forecast period.
North America is expected to account for a significant proportion of the uterine manipulation devices revenue. This is due to an increase in the number of gynecology-related surgical procedures and hospital visits, as well as the availability of well-established healthcare infrastructure, favorable reimbursement policies, and supportive legislative reforms in the healthcare sector. Based on statistics from CMS, healthcare spending in the United States reached USD 3.8 Trillion, climbing by 4.6% in 2019. It accounted for 17.7% of the country’s GDP. The national health spending is predicted to expand at a 5.4% annual pace, reaching USD 6.2 trillion by 2028.
During the projected period, the market in Asia Pacific is expected to grow at a significant pace. The regional market is predicted to develop significantly due to the presence of a huge patient pool and the growing need for technologically improved and cost-effective healthcare solutions.
A rise in the number of clinical trials and significant research and development investments by global market players to penetrate untapped markets in the country as a result of low-cost services is high-impact rendering market drivers. Furthermore, the market expansion is aided by an increase in the number of hospitalizations and significant innovations in developing nations' clinical development frameworks.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market in the USA is expected to grow at a CAGR of 6.2% from 2023 to 2033, to reach a valuation of USD 180.6 Million. During the forecast period, the market is projected to witness an absolute dollar opportunity of USD 81.8 Million.
The market in the United Kingdom is expected to reach a valuation of USD 25.1 Million by 2033. Growing with a CAGR of 6.2% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around USD 11.4 Million.
In Japan, the market is expected to grow at a CAGR of 5.8% from 2023 to 2033, reaching around USD 21.3 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of USD 9.2 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around USD 11.6 Million by 2033, growing at a CAGR of 5.2% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around USD 4.7 Million.
With a market share of over 55% in 2022, the uterine manipulation equipment market through hospitals is expected to garner significant demand. Its growth is mostly due to an increase in the number of patients suffering from various gynecological problems, as well as the number of surgical procedures performed as a result.
Hospitals provide greater patient care and reimburse for specific operations, which is contributing significantly to revenue growth. In addition, hospitals are becoming more technologically advanced. In order to give better care, hospitals are increasingly using technologically advanced technology. These devices not only make treatment procedures easier, but they also deliver better, faster, and more precise results.
The growing number of uterus surgeries, increased attention on woman health hygiene, public awareness of various new advanced technologies, and growing concerns about health problems and the need to cure them are all projected to boost the global market for uterine manipulator devices.
The key players in the global Uterine Manipulation Devices market are Conkin Surgical Instruments Ltd, Johnson and Johnson, CooperSurgical Inc, B. Braun Medical Ltd, and KARL STORZ GmbH & Co. KG.
The market is valued at USD 315 million in 2023.
Conkin Surgical Instruments Ltd, Johnson and Johnson, and CooperSurgical Inc are the prominent market players.
The market is forecast to register a CAGR of 6.1% through 2033.
The market is predicted to be worth USD 570.3 million by 2033.
From 2018 to 2022, the market secured a CAGR of 5.4%.
1. Executive Summary 2. Market Overview 3. Market Risks and Trends Assessment 4. Market Background and Foundation Data Points 5. Key Success Factors 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 8.1. Total Laparoscopy Hysterectomy (TLH) 8.2. Laparoscopic Supracervical Hysterectomy (LSH) 8.3. Laparoscopically Assisted Vaginal Hysterectomy (LAVH) 8.4. Sacrocolpopexy 8.5. Other Applications 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 9.1. Overall 9.2. Hospitals 9.3. Clinics 9.4. Ambulatory Surgery Centers (ASCs) 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. Asia Pacific 10.5. Middle East and Africa (MEA) 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17. Market Structure Analysis 18. Competition Analysis 18.1. Conkin Surgical Instruments Ltd. 18.2. Johnson and Johnson 18.3. CooperSurgical, Inc. 18.4. B. Braun Medical Ltd. 18.5. KARL STORZ GmbH & Co. KG 18.6. CONMED Corporation 18.7. RUDOLF Medical GmbH + Co. KG 18.8. LiNA Medical ApS 18.9. Richard Wolf GmbH 18.10. Utah Medical Products, Inc. 18.11. Purple Surgical 18.12. Clinical Innovations, LLC 18.13. Bissinger Medizintechnik 18.14. The O.R. Company (Symmetry Surgical Inc.) 18.15. LSI Solutions, Inc. 19. Assumptions and Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Uterine Manipulation Devices Market
